BIOMAT Database Logo BIOMAT Database Logo

Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase. 1974

O Y King, and J R Wilbur, and D M Mumford, and W W Sutow

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004885 Erwinia A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.
February 2010, Pediatric blood & cancer,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
August 1972, Cancer,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
January 1999, Klinische Padiatrie,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure.
February 2000, Annals of oncology : official journal of the European Society for Medical Oncology,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.
February 2016, Pediatric blood & cancer,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
July 1992, Cancer,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.
January 2011, Cancer,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia.
October 1998, Leukemia,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
January 1993, Haematologica,
O Y King, and J R Wilbur, and D M Mumford, and W W Sutow
A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia.
January 2019, Pediatric blood & cancer,
Copied contents to your clipboard!